Fed. Circ: Claim Construction & Doctrine of Equivalents – The National Law Review
Fed. Circ: Claim Construction & Doctrine of Equivalents The National Law Review
Archive for May, 2021
-
In: PATENT NEWS
-
In: PATENT NEWS
RI backs call for vaccine patent waiver – Tue, May 11 2021 – Jakarta Post
RI backs call for vaccine patent waiver – Tue, May 11 2021 Jakarta Post
-
In: PATENT NEWS
Full Fed. Circ. Won’t Review Becton’s Wins On Drug Dosing IP
It said the full court should hold the panel and PTAB to a provision of the Patent Act and U.S. Supreme Court and Federal Circuit precedent that …
-
In: PATENT NEWS
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent – Bloomberg Law
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent Bloomberg Law
-
In: PATENT NEWS
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent · More from Bloomberg Law.
-
In: PATENT NEWS
Hilti Win Over Electrical Box Patent Claims Affirmed on Appeal – Bloomberg Law
Hilti Win Over Electrical Box Patent Claims Affirmed on Appeal Bloomberg Law
-
In: PATENT NEWS
Legal and Regulatory Issues in Biotechnology – Course
c) This course will introduce students to the interrelated fields of patent law, regulatory law, and contract law that are vital to the biotech and …
-
In: PATENT NEWS
Beware unintended consequences of proposals to tackle IP theft, warns trade secrets guru
Five years after legislation significantly improved trade secret protection in the US, Jim Pooley tells IAM in an interview, more policymakers on Capitol …
-
In: PATENT NEWS
Hilti Win Over Electrical Box Patent Claims Affirmed on Appeal
IP Law. The Federal Circuit agreed with Hilti that Fireblok failed to identify any …
-
In: PATENT NEWS
United States: Trial Win Paves Way For Lower-Cost Generic Hypertension Drug
Shrestha focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution and opinion work in the chemical, …